LTD The First Medical Center

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis3 trials
• Psoriasis2 trials
• Psoriatic arthritis2 trials
• Crohn's disease1 trial
• Lupus (SLE)1 trial
• Obesity1 trial
• Ulcerative colitis1 trial

Phase

• Phase 25 trials
• Phase 33 trials
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Recruiting3 trials
• Completed2 trials

Lead sponsor

• Janssen Research & Development, LLC3 trials
• Boehringer Ingelheim2 trials
• Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
• Aphaia Pharma US LLC1 trial
• PureTech1 trial

Running trials

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

  NCT07008456· Phase 2· Aphaia Pharma US LLC· Source

  Contact: Maia Kobulia, MD Prof.

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source

  Contact: Ekaterine Labadze (principal investigator)

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· PureTech· Source

• Active, not recruiting

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· Phase 4· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Lupus (SLE)1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

  NCT06241560· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

  NCT05611671· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source